Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter E Clark

Showing results (101-110 of 239) with videos related to

Pageof 24
Sort By:
American Journal of Clinical Oncology|April 7, 2007
A simple model predicts freedom from biochemical recurrence after low-dose rate prostate brachytherapy aloneMichael A Papagikos, Peter J Rossi, James J Urbanic, et al.
Journal of Pediatric Surgery|March 13, 2010
Infant communicating hydroceles--do they need immediate repair or might some clinically resolve?Michelle E Koski, John H Makari, Mark C Adams, et al.
The Journal of Urology|April 22, 2008
Waiting time from initial urological consultation to nephrectomy for renal cell carcinoma--does it affect survival?Andrew A Stec, Benjamin J Coons, Sam S Chang, et al.
Molecular and Clinical Oncology|April 25, 2022
Clinical outcomes associated with expression of aurora kinase and p53 family members in muscle-invasive bladder cancerEarle F Burgess, Chad Livasy, Sally Trufan, et al.
AJR. American Journal of Roentgenology|June 23, 2004
Percutaneous CT-guided radiofrequency ablation of renal neoplasms: factors influencing successRonald J Zagoria, Ashley D Hawkins, Peter E Clark, et al.
BJU International|September 24, 2011
Tumour size, tumour complexity, and surgical approach are associated with nephrectomy type in small renal cortical tumours treated electivelyGregory J Broughton, Peter E Clark, Daniel A Barocas, et al.
Cancer Research|April 2, 2014
NF-κB gene signature predicts prostate cancer progressionRenjie Jin, Yajun Yi, Fiona E Yull, et al.
Cancer|August 5, 2006
Vinorelbine, doxorubicin, and prednisone in androgen-independent prostate cancerLester S Borden, Peter E Clark, James Lovato, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 14, 2013
Current concepts in penile cancerPhilippe E Spiess, Simon Horenblas, Lance C Pagliaro, et al.
The American Journal of Pathology|October 11, 2011
β-Catenin and K-RAS synergize to form primitive renal epithelial tumors with features of epithelial Wilms' tumorsPeter E Clark, Dina Polosukhina, Harold Love, et al.
Pageof 24

Showing results (101-110 of 239) with videos related to

Sort By:
Pageof 24
American Journal of Clinical Oncology|April 7, 2007
A simple model predicts freedom from biochemical recurrence after low-dose rate prostate brachytherapy aloneMichael A Papagikos, Peter J Rossi, James J Urbanic, et al.
Journal of Pediatric Surgery|March 13, 2010
Infant communicating hydroceles--do they need immediate repair or might some clinically resolve?Michelle E Koski, John H Makari, Mark C Adams, et al.
The Journal of Urology|April 22, 2008
Waiting time from initial urological consultation to nephrectomy for renal cell carcinoma--does it affect survival?Andrew A Stec, Benjamin J Coons, Sam S Chang, et al.
Molecular and Clinical Oncology|April 25, 2022
Clinical outcomes associated with expression of aurora kinase and p53 family members in muscle-invasive bladder cancerEarle F Burgess, Chad Livasy, Sally Trufan, et al.
AJR. American Journal of Roentgenology|June 23, 2004
Percutaneous CT-guided radiofrequency ablation of renal neoplasms: factors influencing successRonald J Zagoria, Ashley D Hawkins, Peter E Clark, et al.
BJU International|September 24, 2011
Tumour size, tumour complexity, and surgical approach are associated with nephrectomy type in small renal cortical tumours treated electivelyGregory J Broughton, Peter E Clark, Daniel A Barocas, et al.
Cancer Research|April 2, 2014
NF-κB gene signature predicts prostate cancer progressionRenjie Jin, Yajun Yi, Fiona E Yull, et al.
Cancer|August 5, 2006
Vinorelbine, doxorubicin, and prednisone in androgen-independent prostate cancerLester S Borden, Peter E Clark, James Lovato, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 14, 2013
Current concepts in penile cancerPhilippe E Spiess, Simon Horenblas, Lance C Pagliaro, et al.
The American Journal of Pathology|October 11, 2011
β-Catenin and K-RAS synergize to form primitive renal epithelial tumors with features of epithelial Wilms' tumorsPeter E Clark, Dina Polosukhina, Harold Love, et al.
Pageof 24